Related Experiment Videos
Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast
Breast Cancer Research and Treatment
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018).
ESMO real world data and digital oncology·2026
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival.
Respiratory medicine and research·2019
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data].
Revue des maladies respiratoires·2019
Implementation and evaluation of the Routine Assessment and Integration of Screening for Employment (RAISE) program in adults with metastatic breast cancer.
Breast cancer research and treatment·2026
Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability.
Breast cancer research and treatment·2026
HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted therapy in patients with HER2-positive breast cancer.
Breast cancer research and treatment·2026
Geographic access to triple negative breast cancer clinical trials: are trials located near patients?
Breast cancer research and treatment·2026